Thank you for taking my question. My first question is, can you comment on the ramp-up of Iodine contrast media and the status of Gadolinium -based contrast media that we are working on?
Yes. I want to know the status of our Iodine contrast media ramp -up and our status on the Gadolinium-based contrast media that we have been working on?
I have two questions. The first question is, can you please help us understand how our Contrast Media scale-up is progressing and when a CSM Gadolinium products should get launched?
Got it. My second question is that many pharma companies have announced U.S. capex , including capex for APIs. So, does this news have any negative impact on Divi’s?
So my question is regarding the generic segment. Can you please help us with the plan and timelines for the new product pipeline that you had previously mentioned? And when would these products be launched? And what does the timeline look like?
So for my second question, regarding the U.S. tariffs, could you please comment on what sort of cost advantage India and Indian CDMOs have versus the U.S.? And what sort of tariffs would set off this cost advantage?
Yeah. I just wanted to learn about the launch time lines, particularly for olaparib. Do we have any information on that?
Got it. Okay. That’s all.
Sir, a few questions. So why is the goodwill rising in the first half of the year balance sheet versus FY '25? Have we made any acquisitions?
Got it. Okay. Then could you explain what the driver of the unrealized gains and losses in the cash flow statement of INR19 crores in H1? And where is it included in the P&L?
Hi, sir, thank you for taking my questions. Sir, for the Enzene business, could you please tell me what the current year revenue and margins are?
And do we know the margins yet?
Hi, sir. Congratulations on the good set of numbers. I have two questions. The first question is, why has COGS gone up this quarter?
And the second question is, what are the key cost items that are driving up the other expenses? And are these cost items recurring?